Article
Evaluation of the Point of Care Molecular Diagnostic Genedrive HCV ID Kit for the detection of HCV RNA in clinical samples.
2020-05-14
Abstract excerpt
BACKGROUND Despite the availability of an effective treatment for HCV infection, major bottle neck in the HCV care cascade is difficulty in getting the HCV RNA done on serologically positive (antibody to HCV) patients. This is due to the limited availability of HCV RNA test in the periphery. Nucleic acid amplification testing at point of care might revolutionise the HCV care continuum through its increased sensiti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8160c04-6ac6-54b8-979f-16d03830cfed
- DOI
- 10.1101/2020.05.10.20097576
